News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

With Trial Complete, Saegis Pharmaceuticals, Inc. Eyes Series D In 2006



12/30/2005 11:11:04 AM

With $6 million in the bank as a result of a summertime Series C round, Saegis Pharmaceuticals Inc. has completed a Phase IIa study and may consider a Series D round in 2006, President and Chief Executive Rodney Pearlman told VentureWire. http://www.saegispharma.com



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES